NEW WHITE PAPER:  Solving Atypical Protein Expression with Transposase Technology    Dive in today!
Contact Us
Contact Us

AGC Biologics

1 min read

AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate

July 29, 2025 at 7:00 AM
Press Release Microbial
Read press release
AGC Bio Seattle and Chiba site buildings

1 min read

From Seattle to Chiba: Okayama University Taps AGC Biologics' Global Pathway for New Therapeutic

July 16, 2025 at 5:00 PM
Mammalian & mAbs Press Release
Read press release
AGC Biologics team member working in the cell therapy process development lab

2 min read

AGC Biologics Expands Cell Therapy Development Operations to Asia to Serve Growing Market Need

June 25, 2025 at 5:02 PM
Cell & Gene Therapy Press Release Business Updates
Read press release
cell therapy services from AGC Biologics will support Quell Therapies

2 min read

AGC Biologics Partners with Quell Therapeutics to Advance T-Regulatory Cell Therapies for Immune Disorders

May 15, 2025 at 3:45 AM
Cell & Gene Therapy Press Release
Read press release
AGC Biologics to support Novelty Nobility for antibody drug candidate

2 min read

AGC Biologics Partners with Novelty Nobility for Cell Line Development and Phase I Preparations of Antibody Drug Candidate

May 5, 2025 at 4:00 PM
Mammalian & mAbs Press Release
Read press release
AGC Biologics Yokohama Facility begins GMP production in 2027

2 min read

AGC Biologics Strengthens Single-Use Technology Network, Adds 5,000 L Vessels from Thermo Scientific to New Yokohama, Japan Facility

April 7, 2025 at 3:51 PM
Mammalian & mAbs Press Release
Read press release
AGC Biologics announces new cell and gene business division

3 min read

AGC Biologics Launches New Dedicated Cell and Gene Business Division

April 2, 2025 at 12:25 PM
Cell & Gene Therapy Press Release
Read press release

1 min read

AGC Biologics Honored at CDMO Leadership Awards for Excellence in Quality, Biologics and Cell and Gene Therapies

March 10, 2025 at 2:41 PM
Cell & Gene Therapy Mammalian & mAbs Press Release Microbial
Read press release
Adaptimmune and AGC Biologics Partnership

2 min read

AGC Biologics’ Milan Site to Prepare Lentiviral Vector Commercial Manufacturing for Adaptimmune’s Lete-Cel Product

January 16, 2025 at 5:30 AM
Cell & Gene Therapy Press Release
Read press release
AGC Biologics’ Cell and Gene Center of Excellence expands exosome work with new project.

2 min read

Pandorum Partners with AGC Biologics to Support Clinical Manufacturing of Exosome-Based Kuragenx, a Treatment of Ulcerative Corneal Blindness

January 9, 2025 at 7:00 AM
Cell & Gene Therapy Press Release
Read press release
Prev 1 2 3 4 5 Next